Zephyrnet Logo

Tag: LSE

MakerDAO To Commence Endgame Overhaul This Summer – The Defiant

Maker’s co-founder proposes roadmap for Endgame rollout.MakerDAO is gearing up to accelerate the adoption of its Endgame overhaul.On March 12, Rune Christensen, the co-founder...

Top News

Oslo-based Verdane closes Edda III past target at €1.1 billion doubling its predecessor fund | EU-Startups

Verdane, a European specialist growth investment firm, announced the successful final close of Verdane Edda III (“Edda III” or “the Fund”) at €1.1 billion,...

CAB Payments CEO steps down following disappointing LSE float

The CEO of CAB Payments is stepping down...

Cornerstone Announces 100% Revenue Increase in 2023

UK-based financial services company Cornerstone FS plc (LSE: CSFS) announced significant growth in its 2023 financial results, showing 100% revenue increase to £9.6 million. The company provides...

XVIVO Reaches Milestone in Italy: 1,200 Lifesaving Perfusions Performed with Liver Assist | BioSpace

GOTHENBURG, SWEDEN / ACCESSWIRE / December 22, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) In 2014, XVIVO introduced an innovative liver technology to the Italian...

From Policy to Practice: From Policy to Practice: Understanding Asia’s Climate Legislation Asia’s Climate Legislation

Climate Legislation in Asia  Everything you need to know about Climate Legislation in Asia. China China has committed to achieving carbon neutrality by 2060. Intending to generate...

Equals’ Stock Soars 11% amid Buyout and Dividend Plans

The shares of fintech company Equals Group, which specializes in payments for enterprises and SMEs, surged more than 11% on Wednesday, reaching their highest...

FSMA: Scammers Pose as Major Banks

Scammers have found a new way to deceive unsuspecting consumers by impersonating major banks despite repeated warnings dating back to 2021, the Financial Services and Markets...

Sept. 28 Quick Takes: FDA approves Amicus’ Pompe disease therapy

ARTICLE | RegulationPlus: J&J’s Rybrevant raises the bar and updates from Harbinger, Gritstone, Merck, Immunovant, Evozyne, PTC   By BioCentury Staff September 29, 2023 12:10 AM UTC FDA Thursday approved late-onset...

Datopotamab Deruxtecan Demonstrated Statistically Significant and Clinically Meaningful Progression-Free Survival Benefit in Patients with HR-Positive, HER2-Low or Negative Breast Cancer in TROPION-Breast01 Phase III...

A trend in improvement for the dual primary endpoint of overall survival (OS) was observed for datopotamab deruxtecan versus chemotherapy. Data for OS were...

5 Insane Benefits of Trading in the Financial Markets

Day trading has slowly become one of the most popular approaches to make money online. Its popularity surged during the COVID-19 pandemic when most...

Plus500, N26, payabl. and More: Executive Moves of the Week

It's midway through September, and we notice a drop of 50% in the number of new executives that have been onboarded this week in...

LSE Group Plans to Offer Blockchain-Powered Market For Traditional Assets: Report

Please note that our privacy policy, terms of use, cookies, and do not sell my personal information has been updated.The leader in news and...

Latest Intelligence

spot_img
spot_img